Sociodemographic, Functional and Clinical Correlates in Outpatients with Schizophrenia: Comparison with Affective Disorders
- 1 October 2007
- journal article
- research article
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 41 (10) , 809-818
Abstract
Objectives: To describe the demographic, social and functional characteristics and service utilization of people with schizophrenia attending four public psychiatric services in New Zealand and to compare this with (i) people with severe affective disorders attending the same four services and (ii) the New Zealand general population; and to examine conformity with evidence-based pharmacological treatment of schizophrenia. Methods: Clinical files for all adult outpatients attending the four specialist services were reviewed in October 2004 (n =6164). Patient characteristics, social and functional indicators, diagnosis, duration of illness, and admission information were recorded and analysed for schizophrenia, bipolar disorder and depression (n =5032). Antipsychotic treatment was recorded for those with schizophrenia. Results: Outpatients with schizophrenia made up 47% of the outpatient population; 66% were male, the mean age 39 years and the mean illness duration was 14 years. Sixty-seven percent of schizophrenia outpatients had never been married, 69% had no regular occupational activity, 49% had no formal qualifications, 24% were living in group homes and 26% were treated compulsorily. These characteristics were consistently different compared to outpatients with severe affective disorders and the general population; schizophrenia patients were the most impaired, depression the least and the bipolar group in between. The majority of schizophrenia patients received evidence-based antipsychotic treatment; 84% received monotherapy; 81% prescribed an atypical; 33% prescribed clozapine. Conclusions: The study shows significant impairment for schizophrenia patients in areas of intimate relationships, occupational activity, living situation, qualifications and specialist mental health service use despite evidence-based pharmacological treatment. To improve outcome optimal care must incorporate existing evidence-based, cost-effective interventions that focus on both symptoms and function. More effective treatments also need to be developed.Keywords
This publication has 17 references indexed in Scilit:
- Trends in Antipsychotic Prescribing in Schizophrenia in AucklandAustralasian Psychiatry, 2006
- Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Treatment of Schizophrenia and Related DisordersAustralian & New Zealand Journal of Psychiatry, 2005
- An Audit of Outpatient Antipsychotic Usage in the Three Health Sectors of Auckland, New ZealandAustralian & New Zealand Journal of Psychiatry, 2004
- A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorderCurrent Medical Research and Opinion, 2004
- Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic ImperativeAmerican Journal of Psychiatry, 2004
- Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settingsActa Psychiatrica Scandinavica, 2002
- Recovery from severe mental illness: an intrapersonal and functional outcome definitionInternational Review of Psychiatry, 2002
- Outpatients with schizophrenia and bipolar I disorder: do they differ in their cognitive and social functioning?Psychiatry Research, 2001
- Estimating the burden of disease in an English regionJournal of Public Health, 1997
- Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesArchives of General Psychiatry, 1988